06:47 AM EST, 02/04/2025 (MT Newswires) -- Merck ( MRK ) reported Q4 non-GAAP earnings Tuesday of $1.72 per share, up from $0.03 a year earlier.

Analysts polled by FactSet expected $1.61.

Sales for the quarter ended Dec. 31 were $15.62 billion, up from $14.63 billion a year earlier.

Analysts surveyed by FactSet expected $15.48 billion.

For the full year 2025, Merck ( MRK ) expects non-GAAP EPS of $8.88 to $9.03 on sales of $64.1 billion to $65.6 billion. Analysts polled by FactSet expect non-GAAP EPS of $9.13 from sales of $67.07 billion.

Meck shares fell more than 8% in premarket trading.